IMCC
IMCC
NASDAQ · Pharmaceuticals

Im Cannabis Corp

$0.16
-0.01 (-7.09%)
As of Jun 23, 10:14 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,062.5% upside
Low Target $2.21
Average Target $3.54
High Target $4.26
Current Price $0.16
Current
$0.16
Target
$3.54
$2.21 $3.54 avg $4.26
Scenario Analysis
Bear Case
$2.21
1,250.0%
Low target
Base Case
$3.54
+2,062.5%
Avg target
Bull Case
$4.26
+2,502.3%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$9.70
-98.3% from high
52-Week Low
$4.94
+-96.7% from low
Target vs 52W High
$3.54
-63.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%